HHS Secretary Robert F. Kennedy Jr. is proposing to strip public participation from much of the business his agency conducts ...

It's the second year in a row that Lilly has used the Oscars as a platform to drive home a message about GLP-1-based obesity ...

To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...

Michael Headrick says he’s lost 18 pounds since starting Zepbound injections about a month ago, with no noticeable side effects. (Photo courtesy of Adam Seif) Michael Headrick of Indianapolis ...

Every month, roughly 100,000 people buy Zepbound directly from Eli Lilly through its website. "It's about the size of a small ...

It’s hard to turn on the TV these days without seeing ads for drugs like Ozempic, Wegovy, Zepbound or Mounjaro. These ...

While the Super Bowl may not always be the ideal spot for pharma, cultural events like the Oscars can offer a more ...

Advertisement Article continues below this ad Wegovy and Zepbound are part of a GLP-1 class of treatments that has shown ...

Nick Blackmer is a librarian, fact-checker, and researcher with more than 20 years of experience in consumer-facing health and wellness content. Eli Lilly has reduced the prices of certain ...

FRIDAY, March 7, 2025 (HealthDay News) -- The makers of two popular weight-loss drugs — Wegovy and Zepbound — are cutting ...

Though the Healthy Skepticism ads don’t specifically call out compounded GLP-1s, Lilly said in a statement to MM+M that ...

Less than two weeks after Zepbound-maker Eli Lilly reduced the price of the weight-loss drug, competitor Novo Nordisk said Wednesday it would cut the price of its popular weight-loss drug Wegovy ...